• Home
• GJF
  • Joint Wound Care Formulary
  • . . . Introduction
  • 1. Gastro-Intestinal System
  • 2. Cardiovascular System
  • 3. Respiratory System
  • 4. Central Nervous System
  • 5. Infections
  • 6. Endocrine System
  • 7. Obstetrics, Gynaecology and Urinary Tract Disorders
  • 8. Malignant Disease and Immunosuppresion
  • 9. Nutrition and Blood
  • 10. Musculoskeletal and Joint Disease
  • 11. Eye
  • 12. Ear, Nose and Oropharynx
  • 13. Skin
  • 14. Immunological products and vaccines
  • 15. Anaesthesia
    • 15.1 General anaesthesia
      • 15.1.1 Intravenous Anaesthetics
      • 15.1.2 Inhalational Anaesthetics
      • 15.1.3 Antimuscarinic Drugs
      • 15.1.4 Sedative and Analgesic Peri-Operative Drugs
      • 15.1.5 Muscle Relaxants
      • 15.1.6 Drugs for reversal of neuromuscular blockade
      • 15.1.7 Antagonists for Central and Respiratory Depression
      • 15.1.8 Drugs for Malignant Hyperthermia
    • 15.2 Local anaesthesia
  • Appendix 1. Drugs for emergency use in General Practice
  • Appendix 2. Palliative Care
  • Appendix 3. Oral Nutritional Supplements (ONS)
  • Appendix 4. Gluten-free and cow's milk protein-free products
  • Medicines No Longer included in the GJF
  • Medicines not recommended for use in NHS Grampian
• eGJF
• Medicines Management
• Policies
• News Letters
• Shared Care Protocols
• Patient Group Directions

15.1.8 Drugs for malignant hyperthermia

The drug in this section should only be administered by, or under direct supervision of personnel experienced in their use.

Dantrolene sodium (IV injection) is used in the treatment of malignant hyperthermia, which is a rare, but potentially lethal, complication of anaesthesia.

Previous: Antagonists for central and respiratory depression | Top | Next: Local anaesthesia